Staphylococcus aureus Infections in Children With Congenital Heart Disease

J Chase McNeil1, John A Ligon2, Kristina G Hulten2

  • 1Section of Infectious Diseases and jm140109@bcm.tmc.edu.

Insights

Staphylococcus aureus infections are common in children with congenital heart disease (CHD). Infective endocarditis (IE) is a frequent complication, with prolonged bacteremia and elevated CRP indicating higher risk.

Area of Science:

  • Pediatric Infectious Diseases
  • Cardiology
  • Microbiology

Background:

  • Congenital heart disease (CHD) is a primary risk factor for infective endocarditis (IE) in pediatric populations.
  • Staphylococcus aureus is a leading cause of IE, yet specific risk factors for invasive S. aureus disease in children with CHD remain underexplored.

Purpose of the Study:

  • To investigate the epidemiology of Staphylococcus aureus infections in children diagnosed with congenital heart disease.
  • To identify risk factors and clinical outcomes associated with S. aureus infections in this vulnerable pediatric group.

Main Methods:

  • Retrospective review of clinical and laboratory data from pediatric patients with CHD and S. aureus infection.
  • Analysis of S. aureus isolates for the presence of the qacA/B gene, a marker for antiseptic tolerance.
  • Statistical comparison of clinical variables using Fisher's exact test and Mann-Whitney U tests.

Main Results:

  • 248 S. aureus infections occurred in 216 patients with CHD; 53.6% of isolates were methicillin-resistant.
  • Surgical site infections (28.2%) and bacteremia (20.4%) were common, with IE complicating 29.5% of bacteremic episodes.
  • Prolonged bacteremia, thrombocytopenia, and elevated C-reactive protein (CRP) were associated with IE. The qacA/B gene was detected in 16.9% of isolates, linked to bacteremia and longer hospital stays.

Conclusions:

  • Staphylococcus aureus poses a significant threat, causing substantial morbidity in children with CHD.
  • Infective endocarditis is a frequent complication of S. aureus bacteremia in this cohort. Prolonged bacteremia, thrombocytopenia, and CRP levels >10 mg/dL may aid in IE diagnosis.
  • qacA/B-positive S. aureus isolates are associated with poorer clinical outcomes, highlighting potential targets for intervention.
Abstract

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
62
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
752
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
457
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
849
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
99
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.3K